Literature DB >> 7190020

Interaction of human serum albumin with anticancer agents in vitro.

I Takahashi, T Ohnuma, S Kavy, S Bhardwaj, J F Holland.   

Abstract

The influence of human serum albumin (HA) on the biological effects of 13 chemotherapeutic agents was studied in vitro in the human leukaemia cell line MOLT-3. On the basis of changes in biological activity influenced by HA, these drugs may be divided into three types. Type I agents include cis-diamminedichloroplatinum (II), 4'-(9-acridinylamino)methanesulphon-m-anisidide, neocarzinostatin, nitrogen mustard, adriamycin, daunorubicin and mitomycin C--drugs whose biological activities are reduced in the presence of HA. The biological activities of Type II drugs (cytosine arabinoside, fluorouracil and actinomycin D) are not influenced by HA. The biological activities of Type III drugs (bleomycin, vincristine and vinblastine) are increased in the presence of HA. These results indicate that serum HA interferes in vitro with certain anticancer agents in terms of biological activity and, probably, clinical effectiveness. HA-drug interaction may be a major factor governing the pharmacology of Type I anticancer agents in man.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7190020      PMCID: PMC2010273          DOI: 10.1038/bjc.1980.103

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Some interactions of nitrogen mustards with constituents of human blood serum.

Authors:  J H LINFORD
Journal:  Biochem Pharmacol       Date:  1961-12       Impact factor: 5.858

2.  The pharmacologic disposition of 4'-(9-acridinylamino)methanesulfon-m-anisidide in mice and rats.

Authors:  R L Cysyk; D Shoemaker; R H Adamson
Journal:  Drug Metab Dispos       Date:  1977 Nov-Dec       Impact factor: 3.922

3.  A comparison of the biological effects of dichloromethotrexate and methotrexate on human leukemic cells in culture.

Authors:  I Takahashi; T Ohnuma; J F Holland
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

4.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

5.  Interaction of vinblastine, vincristine and colchicine with serum proteins.

Authors:  D W Donigian; R J Owellen
Journal:  Biochem Pharmacol       Date:  1973-09-01       Impact factor: 5.858

6.  Antitumor activity and pharmacologic disposition of cytosine arabinoside (NSC-63878).

Authors:  R L Dixon; R H Adamson
Journal:  Cancer Chemother Rep       Date:  1965-10

7.  Improved therapeutic index of bleomycin when administered by continuous infusion in mice.

Authors:  B I Sikic; J M Collins; E G Mimnaugh; T E Gram
Journal:  Cancer Treat Rep       Date:  1978-12

8.  Tumor and marrow damage occurring from methotrexate, monofluoromethotrexate, difluoromethotrexate, and dichloromethotrexate.

Authors:  A W VOGEL
Journal:  Cancer Res       Date:  1961-07       Impact factor: 12.701

9.  Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusion.

Authors:  T Ohnuma; C Nogeire; J Cuttner; J F Holland
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

10.  Pharmacokinetic study of cis-dichlorodiammineplatinum(II) (DDP) in the beagle dog: thermodynamic and kinetic behavior of DDP in a biologic millieu.

Authors:  A F LeRoy; R J Lutz; R L Dedrick; C L Litterst; A M Guarino
Journal:  Cancer Treat Rep       Date:  1979-01
View more
  7 in total

Review 1.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 2.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Differential serum protein binding of benzidine- and benzidine-congener based dyes and their derivatives.

Authors:  M Emmett; C E Cerniglia; A J Crowle
Journal:  Arch Toxicol       Date:  1985-06       Impact factor: 5.153

4.  Protein binding of anthraquinone glycosides, with special reference to adriamycin.

Authors:  S Eksborg; H Ehrsson; B Ekqvist
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

5.  Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line.

Authors:  B Hartley-Asp; P O Gunnarsson; J Liljekvist
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 6.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  Weakening Impact of Excessive Human Serum Albumin (eHSA) on Cisplatin and Etoposide Anticancer Effect in C57BL/6 Mice with Tumor and in Human NSCLC A549 Cells.

Authors:  Zhen Yang; Ting Zhou; Yuanchi Cheng; Mingming Li; Xianglin Tan; Feng Xu
Journal:  Front Pharmacol       Date:  2016-11-15       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.